← FDA Drug Approvals (Drugs@FDA)

RANOLAZINE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: TEVA PHARMS · Approved 2016-05-12

Drug application

FDA Application #

ANDA208174

Application type

Abbreviated New Drug Application (Generic)

Brand name

RANOLAZINE

Generic name

Ranolazine

Active ingredients

RANOLAZINE

Dosage form

TABLET, EXTENDED RELEASE

Route

ORAL

Marketing status

None (Tentative Approval)

Sponsor

TEVA PHARMS

First approval

2016-05-12

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown